MLN0128 + MLN1117

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLN0128 + MLN1117, covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma [Phase 2]

See pricing